Auro Laboratories informs about financial results

16 May 2023 Evaluate
Pursuant to Regulation 30 & Regulation 33 of SEBI (LODR) Regulations, 2015, Auro Laboratories has informed that the Board of Directors of the Company at their Meeting held today (i.e., Tuesday, May 16, 2023), has transacted the following business: Approved the Audited Financial Results of the Company for the quarter and year ended March 31, 2023 as recommended by the Audit Committee. In this regard, it has enclosed Audited Financial Results for the quarter and year ended March 31, 2023 along with the Statement of Assets and Liabilities of the Company and Cash Flow Statement as on that date, Auditors Report on the Financial Results for the quarter & year ended March 31, 2023, and declaration regarding Auditor Report with unmodified opinion on the Audited Standalone Financial Results of the Company for the Financial Year ended on March 31, 2023.

The above information is a part of company’s filings submitted to BSE.

Auro Laboratories Share Price

255.95 -0.75 (-0.29%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×